Taken together, these results support the deregulation of arginine synthesis after HSP90 inhibition as a key mechanism with the potential to block cell proliferation in lung adenocarcinoma with mutated EGFR or EML4-ALK translocation. This evidence concerns the gene HSP90AA1 and lung adenocarcinoma.